We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04878029
Brief Title: Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer

First Submitted : April 30, 2021
First Submitted that Met QC Criteria : May 6, 2021
First Posted : May 7, 2021

Last Update Submitted that Met QC Criteria : August 8, 2022
Last Update Posted : August 10, 2022